News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

February 1, 2009

Category

Publications

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Published

September 1, 2006

Categories

PARI Publications
Publications

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

Published

May 12, 2005

Category

PARI Publications

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team